Creative Medical Technology Holding... (CELZ)

$4.92

-0.30 (-5.75%)
Rating:
Recommendation:
-
Symbol CELZ
Price $4.92
Beta 5.244
Volume Avg. 0.05M
Market Cap 7.038M
Shares () -
52 Week Range 3.3-14.2
1y Target Est -
DCF Unlevered CELZ DCF ->
DCF Levered CELZ LDCF ->
ROE -55.29% Strong Sell
ROA -65.05% Strong Sell
Operating Margin -
Debt / Equity -
P/E -0.67
P/B 0.51 Buy
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest CELZ news


Mr. Timothy Warbington
Healthcare
Biotechnology
NASDAQ Capital Market

Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.